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InfectionAlveolar macrophages are immunoregulatory effector cells that interact directly with respiratory virus path-
ogens in vivo. We examined the role of alveolar macrophages in acute infection with pneumonia virus of
mice (PVM), a rodent pneumovirus that replicates the clinical sequelae of severe human respiratory syncytial
virus disease. We show that PVM replicates in primary mouse macrophage culture, releasing infectious vi-
rions and proinﬂammatory cytokines. Alveolar macrophages isolated from PVM-infected mice express acti-
vation markers Clec43 and CD86, cytokines TNFα, IL-1, IL-6, and numerous CC and CXC chemokines.
Alveolar macrophage depletion prior to PVM infection results in small but statistically signiﬁcant increases
in virus recovery but paradoxically prolonged survival. In parallel, macrophage depleted PVM-infected
mice exhibit enhanced NK cell recruitment and increased production of IFNγ by NK, CD4+ and CD8+ T
cells. These results suggest a protective, immunomodulatory role for IFNγ, as overproduction secondary to
macrophage depletion may promote survival despite increased virus recovery.
Published by Elsevier Inc.Introduction
Respiratory syncytial virus (RSV) is a leading cause of acute lower re-
spiratory tract infection in children, and is increasingly recognized as a
signiﬁcant pathogen among the elderly. Although most cases of RSV in-
fection are mild to moderate, severe bronchiolitis, typically in premature
infants, in immunocompromised hosts, and even in thosewith no known
risk factors, involves substantial inﬂammation, with mucus secretion and
sloughing of the bronchiolar epithelium, ultimately leading to respiratory
compromise (Hall et al., 2009; Krilov, 2011; van Bleek et al., 2011).
Alveolarmacrophages are specialized cells of the respiratory tract, and
the predominant leukocyte population at homeostasis; they express
unique cell surface antigens, pattern-recognition receptors and immuno-
modulatory mediators, and function to promote immune surveillance
against microbial invasion (Gordon and Read, 2002; Gordon and Taylor,
2004). Although virus antigens are detectable in alveolar macrophages
isolated from RSV-infected human subjects (Midulla et al., 1993) and vi-
rions are capable of inducing the synthesis and release of proinﬂamma-
tory mediators by both human and mouse macrophages in cultureAID, NIH, Bethesda, MD 20892.
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nc.(Franke et al., 1994; Franke-Ullmann et al., 1995; Matsuda et al., 1996;
Stadnyk et al., 1997; Tsutsumi et al., 1996) the precise contributions of al-
veolarmacrophages to the pathogenesis of RSV disease remain uncertain.
For example, in a study performedby Pribul et al. (2008), RSV-challenged
macrophages in BALB/c mice contributed to the early, immediate re-
lease of pro-inﬂammatory cytokines, although macrophage depletion
had no impact on RSV-mediated T cell recruitment, weight loss, or
lung function. In contrast, Reed et al. (2008) found thatmacrophage de-
pletion prior to RSV challenge resulted in prominent airway occlusion in
association with ongoing disease. Of note, although mouse challenge
models have been employed extensively to study RSV disease, standard
experimental RSV virus strains replicate minimally in commonly-
available wild-type experimental mice and ordinarily elicit a limited
spectrum of clinical symptoms (Bem et al., 2011; Durbin and Durbin,
2004).
Pneumonia virus of mice (PVM, strain J3666) is a highly virulent
natural rodent pathogen of the same family (Paramyxoviridae) and
genus (Pneumovirus) as RSV. First characterized by Horsfall and
Curnen (1946), mice that are inoculated with fewer than 0.1 TCID50
units (Percopo et al., 2011) respondwith robust replication in bronchiolar
epithelial cells, and develop severe acute inﬂammation, which ultimately
progresses to respiratory failure and death, with histopathologic ﬁndings
similar to that of severe RSV infection in human infants (reviewed in
Easton et al., 2006; Rosenberg and Domachowske, 2008).
Here we examine PVM infection in primary macrophage culture
and we explore the impact of macrophage ablation on the pathogen-
esis of and survival in response to acute pneumovirus infection in
vivo.
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PVM replicates in mouse macrophages and elicits production of infec-
tious virions and release of proinﬂammatory cytokines
We previously documented the replication of PVM and produc-
tion of proinﬂammatory cytokines in a mouse macrophage cell line
(RAW 264.7; Dyer et al., 2007). Here we examined PVM replication
in primary cultures of mouse peritoneal macrophages. Similar to
ﬁndings with RAW 264.7 cells, virus recovery from infected mouse
macrophages increased over time [Figs. 1A and B]. To assess the pro-
duction and release of infectious virions, supernatants from PVM-
infected mouse macrophage cultures were harvested and used to
inoculate RAW 264.7 reporter cultures as previously described (Dyer
et al., 2009). Using this method, we detected infectious virions in culture
supernatants from PVM-infected peritoneal macrophage cultures on
days 5 and 7 after inoculation [Fig. 1C]. Interestingly, little to no RSV rep-
lication was reported in primary mouse macrophage culture (Franke et
al., 1994; Franke-Ullmann et al., 1995; Stadnyk et al., 1997), although
Dakhama et al. (1998) identiﬁed a minor population of high-density
guinea pig alveolar macrophages that supported virion assembly. We
also determined that PVM infection induced the expression of tran-
scripts encoding proinﬂammatory mediators CCL2 and CCL3 inFig. 1. PVM replicates in primary mouse macrophages. (A) Macrophage cultures were
inoculated with PVM at day 0; virus recovery was determined by qRT-PCR as described
in Gabryszewski et al. (2011). (B) Total protein extracts from naive macrophage cul-
tures, and cultures inoculated with heat-inactivated (hi) or replication-competent
PVM probed with rabbit polyclonal anti-PVM N protein antibody (NPVM); anti-mouse
β-actin antibody was used as a control for protein loading; three immunoblots from
PVM-infected cultures shown in (B) were evaluated quantitatively by densitometry.
(C) Supernatants from PVM-infected peritoneal macrophage cultures sampled at
time points indicated were used to inoculate RAW 264.7 reporter cultures as described
in Dyer et al. (2009); virus copy number in the reporter cells was assessed by qRT-PCR
at 7 days after inoculation. All data are representative of at least 2 independent exper-
iments performed in quadruplicate; *pb0.05, **pb0.01.peritoneal macrophage cultures [Fig. 2A]; immunoreactive CCL2 and
CCL3were detected in all culture supernatants, but signiﬁcant expression
over background (ie., no virus, heat-inactivated virus inoculations) was
detected in response to PVM infection [Fig. 2B]. CCL2 andCCL3 contribute
signiﬁcantly to the pathogenesis of acute PVM infection inmice (Bonville
et al., 2006; Domachowske et al., 2000); we have shown previously that
blockade of CCL3 signaling results in dramatic improvements in survival
(Bonville et al., 2003, 2004). Likewise, CCL2 and CCL3 are detected prom-
inently in the airway washings of infants with severe RSV disease
(Garofalo et al., 2001; Harrison et al., 1999; McNamara et al., 2005);
Garofalo et al. (2001) have reported an inverse correlation between
levels of CCL2 and CCL3 in the airways and oxygen saturation.
Alveolar macrophages from PVM-infected mice express activation markers
and proinﬂammatory cytokines
Alveolar macrophages display a characteristic antigen proﬁle (F4/
80+CD204+CD11chighCD11blow) that has been used successfully in pu-
riﬁcation strategies (Bedoret et al., 2009; GeurtsvanKessel et al., 2008;
Gough and Gordon, 2000) We show here that this approach can also
be applied to the isolation of alveolar macrophages from lungs of
virus-infected mice, although PVM infection alters the proﬁle of co-
purifying leukocytes. Speciﬁcally, after anti-CD11cmagnetic bead selec-
tion, the target CD204+CD11chighCD11blow cells represented 76% of the
lung cells from uninfected mice [Fig. 3A], but only 31% of the cells from
the infected mice [Fig. 3B]; among the CD11c+ cells from the PVM
infected mice were a prominent, heterogeneous population of
CD204+ CD11clow CD11bhigh cells, likely dendritic cells and monocytes
recruited in response to virus infection. However, the ﬁnal sorting pro-
cedure resulted in 99.3% and 98.5% pure alveolar macrophages from
lung cells of uninfected and infected mice, respectively [Figs. 3C and
D]; this ﬁnding was conﬁrmed by visual inspection [Figs. 3E and F].
RNAwas extracted fromalveolarmacrophages isolated fromuninfected
and infectedmice, and differential expression of activationmarkers and
proinﬂammatory mediators was assessed. Among the most prominent
of these ﬁndings, we report 25-fold increased expression of the C-type
lectin Clec4e, which is a signature gene of activated macrophages
[Fig. 3G]. Clec4e, also known as Mincle (macrophage-inducible C-type
lectin) is a type II membrane protein that detects and interacts with aFig. 2. PVM-infection of mouse macrophages elicits production of proinﬂammatory cy-
tokines. (A) Relative expression of transcripts encoding CCL2 and CCL3 in response to
inoculation with PVM (gray bars) or heat-inactivated (hi) PVM (white bars) normal-
ized to expression in naive cells (no virus control; black bars). (B) Detection of immu-
noreactive CCL2 and CCL3 in supernatants of macrophage cultures described in (A). All
data shown are compiled from two separate experiments run independently in qua-
druplicate; *pb .05, **pb .01, ***pb .001.
Fig. 3. Alveolar macrophages isolated from PVM-infected mice express proinﬂammatory cytokines. Alveolar macrophages (CD204+ CD11blow CD11chigh) were isolated from naive
and PVM-infected mice by positive selection with anti-CD11c-coupled magnetic beads followed by ﬂow cytometric sorting. (A, B) Proﬁles of magnetic-bead isolated, CD204+ cells
from uninfected and PVM-infected mice, respectively. (C, D) Proﬁles of pure, sorted alveolar macrophages from A and B, respectively. (E, F) Cytospin preparations of cells in C and D,
respectively, stained with modiﬁed Giemsa. Flow cytometric proﬁles and Cytospin preparations are representative of 3 separate experiments run independently. (G, H) Alveolar
macrophages were isolated from PVM-infected mice (day 5 after inoculation) and uninfected mice; differential expression was evaluated by RT-PCR array. Data shown are differ-
entially expressed transcripts (infected/uninfected) compiled from three independent experiments (n=15 mice/experimental group).
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mycobacteria), and elicits production of proinﬂammatory cytokines
(Miyake et al., 2010). To the best of our knowledge, this is the ﬁrst re-
port regarding expression of this molecule in associationwith pneumo-
virus infection. Transcripts encoding CD86 were also upregulated,
likewise indicative of an activated phenotype. Among the proinﬂamma-
tory cytokines,we detect augmented expression of transcripts encoding
TNF-α, IL-1 and IL-6, and, consistent with our observations from PVM-
infected macrophages in culture, we observe prominent expression of
Ccl2 and Ccl3 [Fig. 3H]. Expression of Cxcl10 increased dramatically,
more than 500 fold; other chemokine genes differentially expressed in
alveolar macrophages from PVM-infected mice include Ccl5, Ccl17,
Cxcl1, Cxcl2 and Cxcl3. Other transcripts expressed alveolar macro-
phages from PVM-infected mice include IFN-β1 and CXCL11 (data not
shown).Alveolar macrophage depletion results in prolonged survival of PVM-
infected mice
PVM-infected mice typically suffer from marked morbidity, weight
loss and life-threatening respiratory failure, at least in part in response
to the severe, acute inﬂammatory response (Easton et al., 2006;
Rosenberg and Domachowske, 2008). In order to examine the con-
tribution of alveolar macrophages to the pathogenesis of acutepneumovirus infection, these cells were depleted by intratracheal in-
stillation with clodronate-ﬁlled liposomes. As shown in Fig. 4A (also
Suppl. Fig. 1), intratracheal instillation of clodronate-ﬁlled liposomes
(Cl2-MDP-liposomes) resulted in a 25-fold depletion of alveolar macro-
phages (CD204+CD11chighCD11blow cells, as above) from mouse lung
tissue within 24 h that persisted for up to 5 days. Instillation of PBS
alone or an equivalent number of PBS-liposomes had no impact on the
recovery of alveolar macrophages. Mice that received PBS-liposomes
as control 24 h prior to virus inoculation succumbed to the negative se-
quelae of acute PVM infectionwithin 5 to 11 days after inoculation,with
a median survival time of 8 days; Fig. 4B). In contrast, macrophage-
depleted mice experience prolonged survival, with a median survival
time of 9 days (pb0.001). Interestingly, we observed a small but statis-
tically signiﬁcant increase in virus recovery from lung tissue ofmice sub-
jected to alveolar macrophage depletion [Fig. 5A], similar to results of
Pribul et al. (2008) who evaluated macrophage-depleted RSV-
challenged BALB/c mice. Although our results seem paradoxical in light
of the signiﬁcantly prolonged survival, we have previously reported
that changes in peak virus recovery do not necessarily predict survival
(Gabryszewski et al., 2011). Furthermore, we observed that depletion
of alveolar macrophages had no impact on the recruitment of CD4+ or
CD8+ T cells, or on the recruitment of neutrophils or eosinophils
[Figs. 5B–C]. A small but statistically signiﬁcant increase in NK cell re-
cruitment was detected in mice depleted of macrophages [Fig. 5C]. Al-
though the precise role played by NK cells in host defense against
341P. Rigaux et al. / Virology 422 (2012) 338–345pneumovirus infection remains uncertain, relative NK cell deﬁciency
was reported as a feature of severe RSV disease in human infants (De
Weerd et al., 1998); recently, Kaiko et al. (2010) demonstrated that
NK cell depletion of RSV-challenged BALB/cmice resulted in suppression
of IFN-γ production and the development Th2 cytokine responses and
subsequent allergic lung diseaseAlveolar macrophage depletion in PVM-infected mice results in augmented
expression of interferon-gamma
As a further exploration of themechanism of differential survival, the
impact of alveolar macrophage depletion on the production of inﬂam-
matory mediators was evaluated. The most prominent and consistent
response was augmented expression of IFNγ in PVM-infected macro-
phage depletedmice [Fig. 6A]. Consistentwith this ﬁndings, we detected
signiﬁcantly more (and signiﬁcantly greater fractions of) IFNγ+CD4+ T
cells, IFNγ+CD8+ T cells and IFNγ+ NK cells in lung cell suspensions
of PVM-infected, macrophage depleted mice than from their PBS-
liposome treated, PVM-infected counterparts [Figs. 6B–D], although weFig. 4. Alveolar macrophage depletion results in prolonged survival of PVM-infected
mice. (A) Detection of alveolar macrophages (CD204+ CD11chigh CD11blow) by ﬂow
cytometry on days 1 and 5 after intratracheal instillation of PBS (gray bars), PBS lipo-
somes (black bars) or clodronate (Cl2MDP) liposomes (white bars); data shown are
representative of 2 independent experiments (n=5 mice/experimental group);
*pb0.05, ***pb0.001; representative ﬂow proﬁle is shown in Supplemental Fig. 1. (B)
Twenty-four hours before PVM inoculation, mice underwent intratracheal instillation
of Cl2MDP-liposomes (dotted line) or PBS-liposomes (ﬁlled line). Data shown are com-
piled from two separate experiments run independently (n=15 mice/experimental
group); ***pb0.001.Alveolar macrophage depletion results in prolonged survival of
PVM-infected mice. (A) Detection of alveolar macrophages (CD204+ CD11chigh
CD11blow) by ﬂow cytometry on days 1 and 5 after intratracheal instillation of PBS
(gray bars), PBS liposomes (black bars) or clodronate (Cl2MDP) liposomes (white
bars); data shown are representative of 2 independent experiments (n=5 mice/
experimental group); *pb0.05, ***pb0.001; representative ﬂow proﬁle is shown
in Supplemental Fig. 1. (B) Twenty-four hours before PVM inoculation, mice underwent
intratracheal instillation of Cl2MDP-liposomes (dotted line) or PBS-liposomes (ﬁlled
line). Data shown are compiled from two separate experiments run independently
(n=15 mice/experimental group); ***pb0.001.did not determine the fraction of cells that were virus-speciﬁc. There
are currently two papers in the literature that address the role of virus-
speciﬁc CD8+T cells in PVM infection. Both Claassen et al. (2005) and
Frey et al. (2008) note that PVM infection is associated with acute inﬂux
of total CD8+T cells to the lung tissue and airways, respectively. Frey and
colleagues reported that a large fraction of the CD8+T cells isolated from
airways of PVM-infected mice were virus-speciﬁc, speciﬁcally, airway
CD8+T cells expressed IFNγ+ upon exposure to PVM-infected mouse
RAW 264.7 cells ex vivo. In contrast, Claassen and colleagues examined
the responses of CD8+T cells to three dominant PVM-speciﬁc epitopes,
and found that the virus-speciﬁc cells were relatively inactive (IFNγlo
or IFNγ−) during acute infection and for prolonged periods thereafter.
As such, it is not at all clear how to evaluate or how to interpret ﬁndings
regarding virus-speciﬁc IFNγ+CD8+T cells in acute PVM infection.
Likewise, although numerous and prominent antiviral activities of
IFNγ have been documented vis-à-vis other virus infections (Maher et
al., 2007; Schroder et al., 2004), the primary role of this cytokine in pneu-
movirus infection remains unclear (Durbin and Durbin, 2004). Our ﬁnd-
ings are consistent with previously published clinical reports, (Aberle et
al., 2004; Eisenhut, 2008; Garcia et al., in press; Semple et al., 2007)
which suggest a correlation between decreased production of IFNγ and
increasing severity of RSV disease. Among studies that have addressed
the mechanistic relationship between IFNγ and various outcomes of
acute pneumovirus infection, Harker et al. (2010) determined that deliv-
ery of IFNγ via a recombinant bicistronic RSV vector results in attenuated
virus replication, while Culley et al. (2002) suggested that viral replica-
tion and IFNγ-mediated responses may not be directly linked; in thisFig. 5. Impact of macrophage depletion on virus recovery and cell recruitment in re-
sponse to PVM infection. (A) Virus recovery from macrophage-depleted PVM-
infected mice; PVM genome copies were detected by dual standard curve qRT-PCR.
Data shown are representative of 2 independent experiments (n=5–15 mice/
experimental group); ** pb0.01. Cells detected in lung suspensions of macrophage-
depleted (white bars, Cl2MDP liposomes) and control (black bars, PBS liposomes),
PVM-infected mice, including (B) neutrophils (GR-1high) and eosinophils (SiglecF+
CD11c−); (C) CD4+ T cells (CD3+CD4+CD8−), CD8+ T cells (CD3+CD4−CD8+)
and NK cells (CD3−DX5+) at day 6 after inoculation; * pb0.05.
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mice, despite reduced and delayed IFNγ responses in the former group.
In studies focused on secondary responses, Lee et al. (2008) documented
a role for IFNγ signaling in protecting against asthmatic-type responses
in mice upon re-challenge with RSV, as did Hussell and Openshaw
(2000), who noted that IFNγ from IL-12-activated NK cells was a crucial
factor limiting RSV vaccine-mediated immunopathology.
While our results suggest a protective, immunomodulatory role for
IFNγ, Frey et al. (2008) examined PVM infection in IFNγR gene-
deleted mice, and determined that receptor-mediated signaling had
no impact on virus recovery or infection-associated weight loss. The
aforementioned study was carried out in C57BL/6 mice, in contrast to
our ﬁndings, which were generated in BALB/c mice. Ahn et al. (2006)
found that BALB/cmice are substantiallymore susceptible to PVM infec-
tion than C57BL/6 mice. It is possible that IFNγR-mediated signaling
contributes to this differential susceptibility; these hypotheses will
need to be addressed with further experiments. We have shown previ-
ously that IFNγR-mediated signaling is not required to promote sero-
conversion to PVM antigens, although the actions of this cytokine are
crucial for CCL3-mediated neutrophil recruitment (Bonville et al.,
2006, 2009; Ellis et al., 2007). The results featured here suggest that
IFNγmay have a protective, immunomodulatory role in PVM infection
at least in BALB/c mice, as increased expression, observed in the setting
of macrophage depletion, results in prolonged survival despite aug-
mented virus recovery.Fig. 6.Macrophage depletion elicits augmented interferon-gamma response to PVM in-
fection. (A) Interferon gamma (IFNγ; pg/mg lung tissue) detected in macrophage-
depleted PVM-infected mice. (B–D) Total and relative abundance of IFN-γ+ CD4+
and CD8+ T cells, and IFN-γ+ NK cells in lung tissue of macrophage-depleted (white
bars, Cl2MDP liposomes) and control (black bars, PBS liposomes), day 6 after inocula-
tion with PVM. Data shown are representative of 3 independent experiments (n=6
mice/experimental group); *pb0.05, **pb0.01, ***pb0.001.Conclusions
We have shown that the natural rodent pneumovirus pathogen,
PVM, replicates in primary mouse macrophage culture and induces
production and release of infectious virions and proinﬂammatory cy-
tokines CCL2 and CCL3. Alveolar macrophages isolated from PVM-
infected mice express activation markers Clec43 and CD86 as well as
numerous proinﬂammatory cytokines and chemokines. Depletion of
alveolar macrophages by intratracheal instillation with clodronate-
ﬁlled liposomes results in small but statistically signiﬁcant increases
in virus recovery, but, paradoxically, prolonged survival in response
to PVM infection. Alveolar macrophage depletion resulted in an in-
crease in NK cell recruitment, but had no impact on the recruitment
of granulocytes, CD4+ or CD8+T cells. We observe a profound in-
crease in virus-induced expression of IFNγ, in association with signif-
icantly more (and signiﬁcantly greater fractions of) IFNγ+ CD4+ T
cells, IFNγ+ CD8+ T cells and IFNγ+ NK cells present in lung tissue.
Taken together, these results suggest that macrophage-depletion re-
sults in augmented production of IFNγ from multiple sources, unco-
vering a potential protective, immunomodulatory functions of this
pleiotropic cytokine in primary pneumovirus infection.
Materials and methods
Mouse and virus stocks
6–8 week old BALB/c mice were purchased from Division of Cancer
Therapeutics (DCT, National Cancer Institute, National Institutes of
Health). All procedures were reviewed and approved according to Ani-
mal Study Protocol LAD8E, approved by the National Institute of Allergy
and Infectious Diseases (NIAID) Animal Care and Use Committee.
Mouse-passaged PVM strain J3666 was used in all experiments. Virus
copy number in stocks and inocula were evaluated by qRT-PCR target-
ing the unique SH gene as previously described (Gabryszewski et al.,
2011). Prior to inoculation of cells in culture, clariﬁed lunghomogenates
were dialyzed at 4 °C overnight against phosphate buffered saline
(50 kDa MW cut off dialysis tubing, Spectrum Laboratories).
Cell culture
Isolated alveolar and peritoneal macrophages were cultured in
DMEM/F12 supplemented with 10% fetal bovine serum (FBS), 2 mM
L-glutamine, 100 units/mL penicillin, 100 μg/mL streptomycin and
100 IU/mL M-CSF (R&D Systems). RAW 264.7 cells (ATCC TIB-71;
ATCC) were maintained in IMDM supplemented with 10% FBS,
2 mM L-glutamine, 100 units/mL penicillin, and 100 μg/mL streptomycin.
Isolation of peritoneal macrophages and challenge with PVM
Peritoneal cavities of naive mice were lavaged with RPMI 1640 sup-
plemented with 10% FBS, 2 mM L-glutamine, 100 units/mL penicillin,
100 μg/mL streptomycin and 25 μM2-mercaptoethanol. Peritoneal ﬂuids
were pooled and centrifuged (400×g, 5 min). Pelleted cells were sus-
pended in DMEM/F12 supplemented with 10% FBS, 2 mM L-glutamine,
100 units/mL penicillin, 100 μg/mL streptomycin and 100 IU/mL M-CSF
and seeded in culture plates. Cells were permitted to adhere to the plates
for 40 min prior to washing with PBS. Routinely, more than 90% of the
cells obtained by this procedure displayed a macrophage phenotype as
assessed by visual inspection and by anti-F4/80 staining. Peritoneal mac-
rophages were challenged 24 h later with PVM, heat-inactivated PVM
(hiPVM; PVM virions heated to 95 °C and then ﬂash frozen in a dry ice–
methanol bath, repeated 3 times) at a multiplicity of infection (MOI) of
100 or were sham treated with an equal volume of IMDM. The cells
and viruswere co-incubated for 4 h at 37 °C in a humidiﬁed 5% CO2 incu-
bator, after which the cells were washed twice with PBS and placed in
fresh complete medium. At the time points indicated, aliquots of culture
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release by ELISA (R&D Systems), or Western blot probed with anti-PVM
N antibody (Percopo et al., 2011) and anti-beta actin to determine rela-
tive loading (Cell Signaling, Millipore Corporation).
Determination of virus recovery
Mouse lung tissues were stored in RNAlater (Ambion) overnight
at 4 °C prior to RNA extraction. RNA was isolated from lungs with
RNAzol Bee reagent (Tel-Test) according to manufacturer's instruc-
tions. Virus titer was determined by quantitative RT-PCR with two
standard curves (PVM SH gene and cellular GAPDH) as previously de-
scribed (Gabryszewski et al., 2011). Western blot was carried out by
standard procedures. PVM anti-N antibody was characterized as de-
scribed in Percopo et al. (2011).
Release of infectious virions released by cultured macrophages
Supernatants from infected macrophage cultures were collected at
the time points indicated and stored at −80 °C until use. Aliquots of
these culture supernatants (100 μL) were used to inoculate RAW
264.7 reporter cultures seeded in 900 μL of medium. After 7 days,
total cellular RNA was isolated, and virus recovery was determined
by qRT-PCR.
Isolation and identiﬁcation of leukocytes from lungs of PVM-infected
mice
Micewere anesthetized by a brief inoculation of 20% (v/v) halothane
(Ayerst Laboratories) diluted in mineral oil. Anesthetized mice were in-
oculated intranasally with 5×105 copies of PVM strain J3666 in IMDM
or IMDM as control. Five or six days after inoculation, mice were sacri-
ﬁced. A PBS solution supplemented with 10 mM EDTA was injected
into the heart to perfuse lung tissues. Collected lungs were ﬁnely
chopped with a razor blade and digested in RPMI containing 5% FBS,
2 mg/mL collagenase D (Roche Diagnostics) and 20 μg/mL grade II
DNase I (RocheDiagnostics). After 45 min incubation at 37 °C under stir-
ring, 1 volume of fresh digestionmediumwas added; 10 mM EDTAwas
added after a total of 90 min digestion time and the lung digest was
placed on ice for 5 min. The cell suspension was strained onto a 70 μm
nylon mesh and centrifuged (400×g, 5 min, 4 °C). Red cells were lysed
with ACK buffer and remaining cells were washed in PBS containing
2% FBS and 20 μg/mL grade II DNase I. Lung cells were stained with
LIVE/DEAD Fixable Near IR stain (Invitrogen) in PBS (30 min, 4 °C). To
assess neutrophils and eosinophil recruitment to the lung, cells were
then probed with anti-mouse GR-1V450 (BD Biosciences), CD11c
Alexa 488 (eBioscience), Siglec-F PE (BD Biosciences), CD45 PE-Cy5
(BD Biosciences) in HBSS containing 10 mM EDTA, 10% FBS in the pres-
ence of blocking anti-mouse CD16/CD32 (eBioscience) for 20 min at
4 °C. To assess T cell and NK cell recruitment, ﬂuorochrome-coupled an-
tibodies included anti-mouse CD3 FITC (BD Biosciences), CD8 PE (BD
Biosciences), CD4 PerCp-Cy5.5 (eBioscience) and DX5 PE-Cy7 (BD Bio-
sciences). To enumerate alveolar macrophages, cells were probed with
anti-mouse CD11c Alexa 488 (eBioscience), CD11b PE (BD Biosciences)
and CD204 Alexa 647 (AbD Serotec). Parallel samples were stainedwith
isotype-matched controls replacing the aforementioned speciﬁc mAbs.
Antibody-bound cells were washed twice in HBSS supplemented with
10 mM EDTA and 10% FBS and analyzed by ﬂow cytometry (LSRII, BD
Biosciences).
Puriﬁcation of alveolar macrophages
Lung cell suspensions were prepared as described above; CD11c+
lung cells were puriﬁed from isolated lung cells with a murine CD11c+
cells isolation kit (Miltenyi Biotec) in accordance to manufacturer's in-
structions. Live CD11c+ cells were identiﬁed with LIVE/DEAD FixableNear IR stain (Invitrogen) in PBS (30 min, 4 °C) followed by anti-mouse
CD11c Alexa 488 (eBioscience), CD11b PE (BD Biosciences), CD204
Alexa 647 (AbD Serotec) in HBSS containing 10 mM EDTA, 10% FBS,
100 units/mL penicillin, 100 μg/mL streptomycin in the presence of
blocking anti-mouse CD16/CD32 (eBioscience) for 20 min at 4 °C.
Antibody-bound cells were washed twice in HBSS supplemented
with 10 mM EDTA, 10% FBS, 100 units/mL penicillin and 100 μg/mL
streptomycin. CD204+ CD11chigh CD11blow LIVE/DEAD stainlow (via-
ble alveolar macrophages) were sorted by ﬂow cytometry (FACSAria,
BD Biosciences). The purity of sorted cells was >95%. A fraction of
isolated cells was subjected to cytospin, methanol-ﬁxation and staining
with modiﬁed Giemsa (DiffQuik, Fisher Scientiﬁc) to conﬁrm purity
and identiﬁcation as macrophages.
Relative expression of proinﬂammatory cytokines in alveolar macrophages
from PVM-infected mice
RNAwas isolated from sorted alveolar macrophages from both con-
trol and PVM-infected mice using the RT2 qPCR-grade RNA Isolation Kit
(SA Biosciences, Frederick, MD). First-strand cDNAwas generated using
the RT2 First-strand Kit (SA Biosciences) and, in conjunction with the
RT2 SYBR Green/ROX qPCR Master Mix (SABiosciences), analyzed for
differential gene expression using the RT2 Proﬁler Toll-Like Receptor
Signaling Pathway PCRArray and the Inﬂammatory Response andAuto-
immunity PCR Array (SA Biosciences). Alternatively, sorted alveolar
macrophages were seeded in macrophage complete medium (see
above). Alveolar macrophage supernatants were aliquoted at speciﬁed
time points and tested for cytokine production by multiplex bead
array (BioRad) or ELISA (R&D Systems).
Depletion of alveolar macrophages
Clodronate (dichloromethylene diphosphonate, Cl2MDP) or PBS en-
capsulated liposomes (Encapsula Nanosciences) were injected intratra-
cheally. (60 μL, 1:2 dilution in PBS) to each anesthetized naive recipient.
Anesthesia was achieved by injecting 80 μL of 2 mg/mL xylazine,
12.5 mg/mL ketamine in PBS via the intraperitoneal route. Twenty-
four hrs later, mice were infected with 1×105 copies of PVM strain
J3666 after inhalation anesthesia with 20% (v/v) halothane (Ayerst Lab-
oratories) in mineral oil. Mouse survival was evaluated every 24 h.
Whole lung tissue was stored in RNAlater (Ambion) for determination
of virus recovery, or blade-homogenized in ice-cold PBS-BSA 0.01%
(w/v), followed by centrifugation (2000×g, 15 min, 4 °C) for prepara-
tion of clariﬁed tissue homogenates. Clariﬁed supernatants were stored
in aliquots at−80 °C until use. Cytokine concentrationwas determined
by ELISA (R&D Systems). Datapoints were normalized to total protein
content, which was measured by micro BCA protein essay (Pierce
Biotech).
Intracellular cytokine staining
Intracellular cytokine stainingwas performed according to previous-
ly publishedmethods (Foster et al., 2007). Cells were washed twice and
resuspended in RPMI 1640 medium supplemented with 5% FBS, 100 U/
ml penicillin, 100 μg/mL streptomycin and 1 mM L-glutamine. Cells
were sham-stimulated or stimulated with 20 ng/mL phorbol myristate
acetate and 1 μM ionomycin in the presence of 10 μg/mL brefeldin A.
Stimulation was performed in 16-mm×125-mm culture tubes (Corn-
ing, 4×106 cells, 2 mL, 37 °C) with gentle stirring. After 4 h, the samples
were washed twice in cold PBS, labeled with LIVE/DEAD Fixable Violet
Dead Cell Stain (Invitrogen) according to the manufacturer's instruc-
tions, washed in cold PBS, and stained with mAb diluted in PBS contain-
ing 10 mMEDTA, 10% FBS in the presence of blocking anti-mouse CD16/
CD32 (eBioscience) for 20 min at 4 °C. The following 5-color panel was
used: Violet LIVE/DEAD in combination with anti-mouse CD3 FITC (BD
Biosciences), CD8 PE (BD Biosciences), CD4 PerCp-Cy5.5 (eBioscience)
344 P. Rigaux et al. / Virology 422 (2012) 338–345and DX5 PE-Cy7 (BD Biosciences). Cells were washed twice in cold PBS,
ﬁxed in 4% paraformaldehyde (Sigma),washed in PBS and stored 16 h at
4 °C. For intracellular staining, cells were blocked in PBS with 0.1% sapo-
nin and5%nonfat driedmilk for 60 min and stained thereafterwith anti-
mouse IFNγ APC diluted in PBS/saponin/nonfat dried milk for 30 min.
Stained cells were washed twice with PBS, and resuspended in PBS
with 0.1% BSA (w/v) for analysis. Parallel samples were stained with
isotype-matched controls replacing the anti-mAbs.
Statistical analysis
All data points indicate the average of samples±SEM. All analyses
were performed using GraphPad Prism 5 (GraphPad). Log-rank test
was used in survival studies. In other cases, statistical signiﬁcance was
determined by an ANOVA test, followed by a Bonferroni test for com-
parison between groups. Signiﬁcant outliers were excluded by using
Grubbs test. All experiments were repeated at least 2 times to conﬁrm
results.
Supplementary materials related to this article can be found online
at doi:10.1016/j.virol.2011.10.031.
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Glossary
PVM: pneumonia virus of mice
hi: heat inactivated
Cl2MDP: clodronate
IFNγ: interferon gamma
